Navigation Links
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Date:8/31/2010

ility of PharmFilm® for future partners."

Suboxone® sublingual film was developed under a previously undisclosed collaboration between MonoSol Rx and Reckitt Benckiser Pharmaceuticals Inc., in which Reckitt Benckiser's Suboxone® products were formulated utilizing MonoSol Rx's PharmFilm® technology. Under the world-wide agreement, MonoSol Rx will manufacture Suboxone® sublingual films and Reckitt Benckiser will leverage its existing Suboxone® sales force to market the product. MonoSol Rx is eligible to receive pre-launch milestone payments, development fees, supply payments and royalties on net sales.  

Shaun Thaxter, President of Reckitt Benckiser Pharmaceuticals Inc., said, "We are pleased that our positive working relationship with MonoSol Rx has resulted in FDA approval of Suboxone® sublingual film. The development of Suboxone® sublingual film through our exclusive agreement with MonoSol Rx reinforces our commitment to our addiction therapy franchise and to its development.  During clinical studies, Suboxone® sublingual film was shown to be faster dissolving than Suboxone® sublingual tablets, and patients preferred the film. Our partnership with MonoSol Rx, represents a strategic business opportunity which will contribute to the longevity of Suboxone® in the U.S."

About MonoSol RxMonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs. The Company's leadership in film drug delivery is supported by strong intellectual property, a portfolio of commercialized prescription and over-the-counter (OTC) drug products, a pipeline of prescription formulations based on PharmFilm® technology, and two recent FDA approvals - Zuplenz®, the first approved prescription ora
'/>"/>

SOURCE MonoSol Rx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies
2. MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process
3. Glenmark Announces the Discovery of a Novel Chemical Entity GRC 17536, a TRPA1 Receptor Antagonist, a Potential First-in-Class Molecule Globally
4. ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market
5. GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting
6. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
7. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
8. Governor OMalley Announces State Grants Available For Maryland Bio Companies
9. Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
10. Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO)
11. 3SBio Inc. Announces Unaudited Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... The Pittcon marketing department is pleased to announce ... app, Pittcon 2015 . The ... for iOS and Android devices and the Kindle Fire, ... after the event. It acts as an all-inclusive real-time ... Conferee Networking sessions and short courses. , The Pittcon ...
(Date:11/26/2014)... WILMINGTON, DE (PRWEB) November 26, 2014 ... MPN Heroes recognition reception on December 5, 2014, in ... annual meeting. The MPN Heroes event will honor clinicians, ... the field of myeloproliferative neoplasms (MPNs). , Special ... will discuss his family's cancer journey at the reception. ...
(Date:11/26/2014)... 2014 /PRNewswrie/ -- Theravalues Corporation annuncia con orgoglio il ... occasione di Hi Europe 2014 (dal 2 al 4 ... tratta della curcumina con la maggiore biodisponibilità di sempre, ... ingredienti approvati dalle norme europee. La curcumina ... curcumina ( Curcuma longa ) che è stata associata ...
(Date:11/24/2014)... WASHINGTON , Nov. 24, 2014  Last ... G.K. Butterfield (D-NC) took a bold ... diseases by introducing the OPEN Act. Original co-sponsors ... Hastings (D-FL). The Act will incentivize drug makers ... life-threatening rare diseases and pediatric cancers, which opens ...
Breaking Biology Technology:Pittcon Releases 2015 Mobile App 2CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2
... (Wednesday, Sept. 1, 2010) - A new "smart ... developed by University of Waterloo engineering researchers promises ... as medical devices, microelectromechanical systems (MEMS), printers, hard ... The breakthrough technology will provide engineers with much ...
... 1 TriMark Publications, LLC ( http://www.trimarkpublications.com ), a ... publishing, cites in its newly published Regenerative Medicine ... medicine products will exceed $3 billion in 2010 and ... medicine is a technique to treat injuries and diseases ...
... 1, 2010 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
Cached Biology Technology:New process promises to revolutionize manufacturing of products 2Regenerative Medicine Market Expected to Reach $4.5 Billion by 2014 2ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 2ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 3ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 4ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 5ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 6
(Date:11/18/2014)... WASHINGTON , Nov. 18, 2014  The ... Security Industry Association today jointly announce the formation ... and release of its Identity and Biometric ... (Framework). The Framework received official support from BORDERPOL, ... governments to improve and provide expertise regarding border ...
(Date:11/18/2014)... The Parenteral Drug Association (PDA) today confirmed that ... and at least seven more will participate in the upcoming ... Hotel in Washington D.C. , Dec. 2-4. ... support from the regulatory agencies in the United ... our effort to help advance the use of metrics in ...
(Date:11/15/2014)... 2014  While we may still be a few years ... "Star Trek" to gain instant access to all that ailed ... smartphones and tablets for monitoring and measuring our health are ... may seem a tad Orwellian to some, but a new ... these technological opportunities into their healthcare regime. These ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... a researcher from the Tropical Research Institute of Portugal had ... a staple food crop for half of humanity ... shunned by consumers worldwide. She realised she could not do ... collaboration to address a looming threat to world,s rice supplies. ...
... March 17, 2010 -- University of Miami (UM) Rosenstiel School ... developed a new tool to monitor coral reef vital signs. ... how climate change and other ecological threats impact coral reef ... a March 2009 experiment at Cayo Enrique Reef in Puerto ...
... A dendritic cell vaccine personalized for each individual based on ... those with a deadly form of brain cancer called glioblastoma, ... has found. Published this week ... study also identified a subset of patients more likely to ...
Cached Biology News:Chemical-free pest management cuts rice waste 2Chemical-free pest management cuts rice waste 3Study provides new tool to monitor coral reef 'vital signs' 2Personlized dendritic cell vaccine increases survival in patients with deadly brain cancer 2Personlized dendritic cell vaccine increases survival in patients with deadly brain cancer 3
The BioLogic Maximizer mixer is for use with the Maximizer valve system. The mixer improves gradient quality by mixing the output of the BioLogic DuoFlow workstation pumps....
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
... maximum performance on minimum space. Thanks to ... heating and cooling rates have been achieved ... a maximum capacity of 48 x 0.2ml ... of much more expensive 96 well instruments. ...
... Super Sensitive Polymer-HRP IHC ... novel product based on ... technology. This system yields ... noise ratio and minimizes ...
Biology Products: